These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26561829)

  • 1. Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles.
    Loskog A
    Viruses; 2015 Nov; 7(11):5780-91. PubMed ID: 26561829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
    Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
    Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to Oncolytic Virotherapy.
    Engeland CE; Bell JC
    Methods Mol Biol; 2020; 2058():1-6. PubMed ID: 31486028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review).
    Wang X; Zhong L; Zhao Y
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Viruses: Therapeutics With an Identity Crisis.
    Breitbach CJ; Lichty BD; Bell JC
    EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and application of oncolytic viruses for cancer immunotherapy.
    Ylösmäki E; Cerullo V
    Curr Opin Biotechnol; 2020 Oct; 65():25-36. PubMed ID: 31874424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.
    Robinson M; Li B; Ge Y; Ko D; Yendluri S; Harding T; VanRoey M; Spindler KR; Jooss K
    J Virol; 2009 Apr; 83(8):3450-62. PubMed ID: 19193803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic viruses for cancer immunotherapy.
    Hemminki O; Dos Santos JM; Hemminki A
    J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter four--Design of improved oncolytic adenoviruses.
    Alemany R
    Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep.
    de Gruijl TD; van de Ven R
    Adv Cancer Res; 2012; 115():147-220. PubMed ID: 23021245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic viruses from the perspective of the immune system.
    Alemany R; Cascallo M
    Future Microbiol; 2009 Jun; 4(5):527-36. PubMed ID: 19492964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncolytic virus ΔPK has multimodal anti-tumor activity.
    Aurelian L; Bollino D; Colunga A
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27242376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Immunotherapy for Treatment of Cancer.
    Tsun A; Miao XN; Wang CM; Yu DC
    Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs and oncolytic viruses.
    Ruiz AJ; Russell SJ
    Curr Opin Virol; 2015 Aug; 13():40-8. PubMed ID: 25863717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M; Hermiston TW
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic HSV as a vector in cancer immunotherapy.
    Li H; Zhang X
    Methods Mol Biol; 2010; 651():279-90. PubMed ID: 20686972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
    Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
    Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.